The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies

AbstractTracking cancer dynamic protein-protein interactions(PPIs) and deciphering their pathogenesis remain a challenge. Here, we presented a dynamic PPIs’ hypothesis: permanent and transient interactions might achieve dynamic switchings from normal cells to malignancy, which could cause maintenance functions to be interrupted and transient functions to be sustained. Based on the hypothesis, we first predicted more than 1,400 key cancer genes (KCG) by applying PPI-express we proposed to 18 cancer gene expression datasets. Two prominent functional characteristics, “Cell cycle-related” and “Immune-related”, were presented, suggesting that it might be a general characteristic of KCG. We then further screened out key dynamic interactions (KDI) of cancer based on KCG and transient and permanent interactions under both conditions. We found that, compared to permanent to transient KDI pairs (P2T) in the network, transient to permanent (T2P) have significantly higher edge betweenness (EB), and P2T pairs tending to locate intra-functional modules may play roles in maintaining normal biological functions, while T2P KDI pairs tending to locate inter-modules may play roles in biological signal transduction. It was consistent with our hypothesis. Also, we analyzed network characteristics of KDI pairs and their functions. Our findings of KDI may serve to understand and explain a few hallmarks of cancer.

Download Full-text

Essentiality, Protein-Protein Interactions and Evolutionary Properties are Key Predictors for Identifying Cancer Genes Using Machine Learning

10.1101/2021.09.01.458494 ◽

2021 ◽

Author(s):

Amro Safadi ◽

Simon C Lovell ◽

Andrew James Doig

Keyword(s):

Machine Learning ◽

Protein Interactions ◽

Drug Targets ◽

Therapeutic Drug ◽

Cancer Genes ◽

Protein Protein Interactions ◽

Protein Coding ◽

Protein Protein Interaction ◽

Machine Learning Model ◽

Human Genes

The identification of genes that may be linked to cancer is of great importance for the discovery of new drug targets. The rate at which cancer genes are being found experimentally is slow, however, due to the complexity of the identification and confirmation process, giving a narrow range of therapeutic targets to investigate and develop. One solution to this problem is to use predictive analysis techniques that can accurately identify cancer gene candidates in a timely fashion. Furthermore, the effort in identifying characteristics that are linked to cancer genes is crucial to further our understanding of this disease. These characteristics can be employed in recognising therapeutic drug targets. Here, we investigated whether certain genes' properties can indicate the likelihood of it to be involved in the initiation or progression of cancer. We found that for cancer, the essentiality scores tend to be higher for cancer genes than for all protein coding human genes. A machine-learning model was developed and we found that essentiality related properties and properties arising from protein-protein interaction networks or evolution are particularly effective in predicting cancer-associated genes. We were also able to identify potential drug targets that have not been previously linked with cancer, but have the characteristics of cancer-related genes.

Download Full-text

Protein-fragment complementation assays for large-scale analysis of protein–protein interactions

Biochemical Society Transactions ◽

10.1042/bst20201058 ◽

2021 ◽

Author(s):

Ewa Blaszczak ◽

Natalia Lazarewicz ◽

Aswani Sudevan ◽

Robert Wysocki ◽

Gwenaël Rabut

Keyword(s):

Protein Interactions ◽

Drug Targets ◽

Large Scale ◽

Protein Protein Interactions ◽

Protein Fragment ◽

Ppi Networks ◽

Large Scale Analysis ◽

Cellular Environment ◽

Protein Fragment Complementation ◽

Fragment Complementation

Protein–protein interactions (PPIs) orchestrate nearly all biological processes. They are also considered attractive drug targets for treating many human diseases, including cancers and neurodegenerative disorders. Protein-fragment complementation assays (PCAs) provide a direct and straightforward way to study PPIs in living cells or multicellular organisms. Importantly, PCAs can be used to detect the interaction of proteins expressed at endogenous levels in their native cellular environment. In this review, we present the principle of PCAs and discuss some of their advantages and limitations. We describe their application in large-scale experiments to investigate PPI networks and to screen or profile PPI targeting compounds.

Download Full-text

Target-Templated de novo Design of Macrocyclic D-/L-Peptides: Inhibitors of the PD-1/PD-L1 Interaction

10.26434/chemrxiv.11663337.v3 ◽

2020 ◽

Author(s):

Salvador Guardiola ◽

Monica Varese ◽

Xavier Roig ◽

Jesús Garcia ◽

Ernest Giralt

Keyword(s):

Protein Interactions ◽

Cyclic Peptides ◽

General Framework ◽

Large Scale ◽

De Novo ◽

Inhibitory Effect ◽

Original Text ◽

Protein Protein Interactions ◽

Retraction Notice ◽

Pharmaceutical Properties

NOTE: This preprint has been retracted by consensus from all authors. See the retraction notice in place above; the original text can be found under "Version 1", accessible from the version selector above. ------------------------------------------------------------------------ Peptides, together with antibodies, are among the most potent biochemical tools to modulate challenging protein-protein interactions. However, current structure-based methods are largely limited to natural peptides and are not suitable for designing target-specific binders with improved pharmaceutical properties, such as macrocyclic peptides. Here we report a general framework that leverages the computational power of Rosetta for large-scale backbone sampling and energy scoring, followed by side-chain composition, to design heterochiral cyclic peptides that bind to a protein surface of interest. To showcase the applicability of our approach, we identified two peptides (PD-i3 and PD-i6) that target PD-1, a key immune checkpoint, and work as protein ligand decoys. A comprehensive biophysical evaluation confirmed their binding mechanism to PD-1 and their inhibitory effect on the PD-1/PD-L1 interaction. Finally, elucidation of their solution structures by NMR served as validation of our de novo design approach. We anticipate that our results will provide a general framework for designing target-specific drug-like peptides.

Download Full-text

Target-Templated de novo Design of Macrocyclic D-/L-Peptides: Inhibitors of the PD-1/PD-L1 Interaction

10.26434/chemrxiv.11663337 ◽

2020 ◽

Author(s):

Salvador Guardiola ◽

Monica Varese ◽

Xavier Roig ◽

Jesús Garcia ◽

Ernest Giralt

Keyword(s):

Protein Interactions ◽

Cyclic Peptides ◽

General Framework ◽

Large Scale ◽

De Novo ◽

Inhibitory Effect ◽

Original Text ◽

Protein Protein Interactions ◽

Retraction Notice ◽

Pharmaceutical Properties

NOTE: This preprint has been retracted by consensus from all authors. See the retraction notice in place above; the original text can be found under "Version 1", accessible from the version selector above. ------------------------------------------------------------------------ Peptides, together with antibodies, are among the most potent biochemical tools to modulate challenging protein-protein interactions. However, current structure-based methods are largely limited to natural peptides and are not suitable for designing target-specific binders with improved pharmaceutical properties, such as macrocyclic peptides. Here we report a general framework that leverages the computational power of Rosetta for large-scale backbone sampling and energy scoring, followed by side-chain composition, to design heterochiral cyclic peptides that bind to a protein surface of interest. To showcase the applicability of our approach, we identified two peptides (PD-i3 and PD-i6) that target PD-1, a key immune checkpoint, and work as protein ligand decoys. A comprehensive biophysical evaluation confirmed their binding mechanism to PD-1 and their inhibitory effect on the PD-1/PD-L1 interaction. Finally, elucidation of their solution structures by NMR served as validation of our de novo design approach. We anticipate that our results will provide a general framework for designing target-specific drug-like peptides.

Download Full-text

Faculty Opinions recommendation of Comparative assessment of large-scale data sets of protein-protein interactions.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1006598.82257 ◽

2002 ◽

Author(s):

Rob Russell

Keyword(s):

Protein Interactions ◽

Large Scale ◽

Comparative Assessment ◽

Data Sets ◽

Protein Protein Interactions ◽

Large Scale Data ◽

Scale Data ◽

Large Scale Data Sets

Download Full-text

Short loop functional commonality identified in leukaemia proteome highlights crucial protein sub-networks

NAR Genomics and Bioinformatics ◽

10.1093/nargab/lqab010 ◽

2021 ◽

Vol 3 (1) ◽

Author(s):

Sun Sook Chung ◽

Joseph C F Ng ◽

Anna Laddach ◽

N Shaun B Thomas ◽

Franca Fraternali

Keyword(s):

Protein Interactions ◽

Large Scale ◽

Interaction Network ◽

Protein Protein Interactions ◽

Protein Protein Interaction ◽

Ppi Networks ◽

Short Loop ◽

New Strategy ◽

Loop Network ◽

Protein Protein Interaction Network

Abstract Direct drug targeting of mutated proteins in cancer is not always possible and efficacy can be nullified by compensating protein–protein interactions (PPIs). Here, we establish an in silico pipeline to identify specific PPI sub-networks containing mutated proteins as potential targets, which we apply to mutation data of four different leukaemias. Our method is based on extracting cyclic interactions of a small number of proteins topologically and functionally linked in the Protein–Protein Interaction Network (PPIN), which we call short loop network motifs (SLM). We uncover a new property of PPINs named ‘short loop commonality’ to measure indirect PPIs occurring via common SLM interactions. This detects ‘modules’ of PPI networks enriched with annotated biological functions of proteins containing mutation hotspots, exemplified by FLT3 and other receptor tyrosine kinase proteins. We further identify functional dependency or mutual exclusivity of short loop commonality pairs in large-scale cellular CRISPR–Cas9 knockout screening data. Our pipeline provides a new strategy for identifying new therapeutic targets for drug discovery.

Download Full-text